Kinnate Biopharma has been granted a patent for inhibitors of receptor tyrosine kinase effector, RAF, for treating diseases. The compound, or its salt or solvate, has a specific structure outlined in the claim. GlobalData’s report on Kinnate Biopharma gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Kinnate Biopharma, Targeted cancer therapy was a key innovation area identified from patents. Kinnate Biopharma's grant share as of January 2024 was 11%. Grant share is based on the ratio of number of grants to total number of patents.
A recently granted patent (Publication Number: US11814384B2) discloses a compound, or its pharmaceutically acceptable salt or solvate, with a specific structure outlined in Formula (Ia). The compound can have various configurations based on the values of X, Y, and Z, as detailed in the subsequent claims of the patent.
The patent further elaborates on the possible substitutions and configurations of the compound, including the nature of R2 and R3 groups, as well as the heteroaryl group W. Additionally, the patent extends to cover pharmaceutical compositions containing the disclosed compound along with a pharmaceutically acceptable excipient. This patent provides a detailed insight into the structural variations and pharmaceutical applications of the compound, paving the way for potential therapeutic developments in the future.
To know more about GlobalData’s detailed insights on Kinnate Biopharma, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
